|
市場調查報告書
醫學營養領域的主要企業與機會
Opportunities and Key Players in Medical Nutrition
|
醫學營養領域的主要企業與機會 是由出版商Business Insights在2011年07月所出版的。
這份英文市場調查報告書包含Pages: 97 價格從美金4795起跳。
由於全球高齡化與醫療制度的財政壓迫，大家對於新領域的關注逐漸升高。例如以透過整合營養學至癌症的治療計畫，可否改善治療結果為對象的研究進行當中。過去針對特定疾病，僅有些微的產品上市，不過各家公司開始關注今後對於各種疾病的營養條件。
本報告，彙整醫學營養市場的現狀與將來的可能性、市場的成長展望、將來具潛力的治療領域、醫學營養產品的開發、法規、醫療報銷方法、參與市場的主要企業等，由下列摘要形式闡述。
報告摘要
簡介
醫學營養的已確立領域以及新興領域
- 摘要
- 簡介
- 代謝的先天異常
- 營養失調
- 恢復
- 糖尿病
- 腎臟疾病
- 癌症
- 免疫系統與發炎
- 記憶與阿茲海默症
- ・Souvenaid (Nutricia)
- reaZin
- 其他中樞神經疾病
- 心臟疾病、代謝症候群、肥胖
- 結論
開發、法律規範、醫療報銷
- 摘要
- 簡介
- 美國的法律規範
- EU的法律規範
- 產品開發
- 醫療報銷
- 智慧財產權保護
- 結論
將來的市場展望
- 摘要
- 市場成長的課題與機會
- 支持新產品的臨床證據
- 營養基因體學
- 個人化營養
- 新營養補充食品的藥物設計
- 生命週期管理
- 營養補充食品的投遞
- 適合性
- 新市場的開拓：醫療從業人員以及病患的產品接受
- 市場規模
- 結論
附錄
圖表
Abstract
Introduction
A small number of products for specific diseases have been introduced over the
years, but companies have only recently started to focus on the specific
nutritional requirements of patients with different diseases in depth. This
report examines the potential of this burgeoning market by identifying areas
of unmet need and the companies looking to cater to this demand with new
product development.
Features and benefits
- Explore the medical nutrition market as it stands and assess its future
potential.
- Identify factors affecting the future growth of the market
- Identify the key therapeutic areas in which there are established products
or that represent areas of active interest for the future.
- Understand how medical nutrition products are developed, regulated and
reimbursed.
- Identify the key market players and their interest in the future growth of
the medical nutrition sector.
Highlights
The growing, aging population and the fact that healthcare systems across the
globe are under financial pressure are driving interest in this emerging area.
Research is, for example, investigating the possibility that integrating
nutrition in therapeutic schedules for cancer might improve treatment outcomes.
The potential rewards for introducing new products for use by patients with
specific diseases are significant, as deomnstrated by the billion dollar
pharmaceutical markets they represent. However, considerable challenges to
this growing market exist - as yet, no market definition exists and regulatory
requirements remain unclear.
Clinical trials for medical nutrition products are necessary to demonstrate
the efficacy and tolerability of new products and to provide support for any
labeling claims. They usually follow standards set in the pharmaceutical
arena, including elements such as randomization, the use of controls and
double blinding and must stand up to peer review.
Your key questions answered
- What are medical nutrition products?
- In which therapeutic areas is there a market for medical foods?
- Which companies are currently in the medical nutrition market and which
groups are driving the sector forward?
- How are they going to achieve the development, approval and launch of
medical foods in therapeutic areas not conventionally treated with food?
- What are the key factors affecting the development of the medical
nutrition market?
Table of Contents
About the authors
- Sara Sleigh
- Cheryl L Barton
- Disclaimer
EXECUTIVE SUMMARY
- Introduction
- Established and emerging areas for medical nutrition
- Development, regulation and reimbursement
- Future market outlook
Introduction
- Summary
- Medical nutrition: a definition
- Medical nutrition: a short history
- The market for medical nutrition
- Demographics and chronic disease
- Malnutrition
- The increasing economic burden of disease
- Leading companies in the field of medical nutrition
- Report outline
- What is this report about?
Established and emerging areas for medical nutrition
- Summary
- Introduction
- Inborn errors of metabolism
- Malnutrition
- Additional considerations for elderly or sick populations
- Recovery
- Nutrition in peri-operative care
- Medical nutrition for chronic wounds
- Diabetes
- Renal failure
- Cancer
- The immune system and inflammation
- Inflammatory bowel diseases
- Osteoarthritis
- Memory and Alzheimer' s disease
- Souvenaid (Nutricia)
- reaZin
- Other CNS disorders
- Heart disease, metabolic syndrome and obesity
- Omega 3
- Obesity and metabolic syndrome
Development, regulation and reimbursement
- Regulation in the EU
- Changes to regulation in the EU
- Reimbursement
- Intellectual property protection
- Conclusions
Future market outlook
- Challenges and opportunities for market growth
- Clinical evidence to support new products
- Nutrigenomics
- Personalized nutrition
- Discovering novel nutraceuticals
- Lifecycle management
- Delivering nutraceuticals
- Compliance
- Developing new markets: product acceptance by medical professionals and
patients
- Market size
- Conclusions
Appendix
- Research methodology
- Acknowledgements
- Abbreviations
- Glossary
- References
TABLES
- Table: Differences between functional foods, dietary supplements, medical
nutrition products and pharmaceuticals
- Table: Acquisitions of medical nutrition companies by leading companies
(2009 - May 2011)
- Table: Examples of medical nutrition products for use in patients at risk
of malnutrition
- Table: Examples of medical nutrition products for use in patients at risk
of malnutrition due to malabsorptive conditions
- Table: High calorie, low volume products for patients with malnutrition
- Table: Products designed to thicken liquid food to aid swallowing
- Table: Examples of medical nutrition products that aim to improve recovery
from trauma or surgery including post-operative wound healing
- Table: Examples of carbohydrate-based nutritional drinks for use in the
pre-operative setting
- Table: Examples of oral nutritional supplements to support wound healing
in chronic wounds
- Table: Examples of medical nutrition products for diabetes
- Table: Examples of medical nutrition products for people with chronic
renal disease
- Table: Examples of medical nutrition products for management of
osteoarthritis
- Table: Examples of marketed medical nutrition products for cognitive
disorders including dementia and Alzheimer' s disease
- Table: Requirements for clinical data to support the reimbursement of a
new food for special medical purposes in the UK
- Table: Examples of innovative companies discovering new nutraceutical
ingredients
- Table: Global market sizes for leading therapeutic areas of the pharma
market in 2015
FIGURES
- Figure: Medical nutrition on the continuum between food and pharmaceuticals
- Figure: Drivers for growth in the medical nutrition market
- Figure: Percentage of the world population aged over 60
- Figure: World population over 80 (UN estimates)
- Figure: 2010 sales of medical nutrition products by leading companies
- Figure: Established and emerging areas of medical nutrition product
development
- Figure: Examples of inflammatory diseases
- Figure: Comparison of the therapeutic area markets for medical nutrition
- Figure: EU legislative framework
- Figure: Challenges and opportunities in the development of new markets for
medical nutrition products
- Figure: Future opportunities in medical nutrition
|
